You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDL1

Showing 26 - 50 of 745
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Non Small Cell Lung Cancer, Renal Cancer Trial in Clermont-Ferrand (Blood sample)

Recruiting
  • Melanoma
  • +2 more
  • Blood sample
  • Clermont-Ferrand, France
    CHU de Clermont-Ferrand
Jun 16, 2022

Solid Tumor Trial in Richmond (Stereotactic radiotherapy, Biological: humanized anti-PD-1 mAb, Biological: humanized anti-PD-L1

Completed
Has Results
  • Solid Tumor
  • Stereotactic radiotherapy
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 20, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Anti-PD-L1 Monoclonal Antibody IMC-001
  • Punch Biopsy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Liver Cancer Trial in Guanzhou (PD1/PDL1 inhibitor)

Unknown status
  • Liver Cancer
  • PD1/PDL1 inhibitor
  • Guanzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Apr 4, 2021

Lung Cancer, Liver Cancer, Colorectal Cancer Trial in Guangzhou (ipilimumab +pembrolizumab +durvalumab)

Recruiting
  • Lung Cancer
  • +10 more
  • ipilimumab +pembrolizumab +durvalumab
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Jan 10, 2022

Head/Neck Tumor Trial in Guanzhou (PD1/PDL1 inhibitor)

Recruiting
  • Head/Neck Neoplasm
  • PD1/PDL1 inhibitor
  • Guanzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Apr 4, 2021

Non-Squamous NSCLC (NSCLC), Adenocarcinoma of the Lung, Lung Cancer Trial in United States (Docetaxel, Nivolumab, Gemcitabine)

Terminated
Has Results
  • Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
  • +3 more
  • Anderson, Indiana
  • +8 more
Jul 7, 2022

Metastatic Renal Cell Carcinoma, Metastatic Urothelial Carcinoma Trial in New York (Nivolumab, Atezolizumab, Radiation &

Terminated
Has Results
  • Metastatic Renal Cell Carcinoma
  • Metastatic Urothelial Carcinoma
  • New York, New York
    Weill Cornell Medicine - New York Presbyterian Hospital
Aug 26, 2021

Colorectal Cancer, Pancreatic Cancer, Metastatic Cancer Trial in Lyon, Toulouse (Pexidartinib, Durvalumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Lyon, France
  • +1 more
Sep 2, 2021

Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (Avelumab, 2nd generation ADT (abiraterone or

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Avelumab
  • 2nd generation ADT (abiraterone or enzalutamide)
  • New Orleans, Louisiana
    Tulane University School of Medicine
Apr 6, 2022

Advanced Lung Non-Small Cell Carcinoma, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in Boston (Granulocyte-Macrophage

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +4 more
  • Boston, Massachusetts
    Tufts Medical Center
Oct 3, 2022

Advanced Pancreatic Cancer Trial in Hangzhou (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in

Recruiting
  • Advanced Pancreatic Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in combination with Nivolumab
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Mar 8, 2022

Mediastinal Lymphadenopathy, Hilar Lymphadenopathy, Lymphoma Trial in Ancona (No suction EBUS-TBNA, Passive suction through

Not yet recruiting
  • Mediastinal Lymphadenopathy
  • +9 more
  • No suction EBUS-TBNA
  • +2 more
  • Ancona, Italy
    Pulmonary Diseases Unit, Department of Immunoallergic and Respir
May 25, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8

Terminated
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Eribulin Mesylate
  • Houston, Texas
  • +1 more
Oct 27, 2022

Lung Cancer, Mesothelioma Trial in Orbassano (niraparib and dostarlimab)

Recruiting
  • Lung Cancer
  • Mesothelioma
  • niraparib and dostarlimab
  • Orbassano, Turin, Italy
    AOU San Luigi- Department of Oncology
Oct 6, 2021

Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +5 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Serial [18F]FluorodeoxyglucosePET/CT asBiomarker of Therapeutic

Terminated
  • Non-Small Cell Lung Cancer (NSCLC)
  • [18F]fluoroglucose(FDG)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 16, 2021

Cancer Head Neck, Metastatic Cancer, Metastatic Lung Cancer Trial in New Haven (adnectin 18F-BMS-986192 Head and Neck Cancer,

Not yet recruiting
  • Cancer Head Neck
  • +2 more
  • adnectin 18F-BMS-986192 Head and Neck Cancer
  • adnectin 18F-BMS-986192 Brain Metastases
  • New Haven, Connecticut
    Yale University PET Center
Oct 10, 2022

Triple Negative Breast Cancer, Stage IV Breast Cancer, HER2 Negative Trial in United States (Atezolizumab, Carboplatin,

Active, not recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Washington, District of Columbia
  • +5 more
Dec 1, 2022

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in Belgium, United States (Bapotulimab (BAY1905254),

Active, not recruiting
  • Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma
  • Bapotulimab (BAY1905254)
  • Bapotulimab (BAY1905254) + Pembrolizumab
  • Tucson, Arizona
  • +7 more
Jan 12, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Completed
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in London (Avelumab)

Completed
  • T-Cell Lymphoma Relapsed
  • T-Cell Lymphoma Refractory
  • London, United Kingdom
    University College London Hospital
Oct 1, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Erythematotelangiectatic Rosacea Trial in Charlotte, Houston (The Vbeam® Prima System, Oxymetazoline HCL 1% Cream)

Completed
Has Results
  • Erythematotelangiectatic Rosacea
  • The Vbeam® Prima System
  • Oxymetazoline HCL 1% Cream
  • Charlotte, North Carolina
  • +1 more
Mar 18, 2022